APIFormulations

Contract researchContract manufacturing

CENTAUR GROUP

Corporate Profile@

We Impart Health to life

19 78

Formulationsfacility 1 - Goa

WHO

1988

API facility - AmbernathUSFDA \ AFSSAPS

1998

Formulationsfacility 2 - Goa

WHO

Sinarest # 1 prescribed anticold brand in India

1No.

Anticold

1996

Centaur Pharmaestablished in Mumbai

1978

The Centaur footprint spans5 continents & 50 countries

2002

Sinarest1 prescription, every second

2003

Corporate

• One of India's few, fully integrated pharmaceutical players

• Proven proficiencies in new product development, custom synthesis,

contract research and contract manufacturing (CRAM)

• Leveraging competencies to build strategic alliances with global majors

• Centaur foot print encompasses 95 countries including regulated markets

• Global acceptance by the pharmaceutical industry and the medical fraternity

API

Contract manufacturing

Strategically positioned to deliver critical value

Fully scalable 25,000 square metres oral solids formulations facility

USFDA / UK - MHRA / TGA / WHO approved facility at Pune near Mumbai

Annual capacity - 3 billion tablets & 600 million capsules

1200 Square meters R & D Formulation with Analytical Development Section

On the anvil - Opthalmics - 12 Million/pa.

•

•

•

•

•

•

India's largest manufacturer and exporter of Psychotropic API•

• Introduced 28 API for the first time in India

• Core competencies- API conceptualisation to commercialisation

• Clientele- Big pharma and generic majors

• USFDA / EU / TGA / WHO approved; ISO 9001: 2008, ISO 14001: 2004,

BS OHSAS 18001: 2007 Certified facility near Mumbai

2004

R&D - APICentaur House - Mumbai

2005

R&D FormulationsCentaur House - Mumbai

2005

Formulations facility 3 - Pune,

USFDA / EU / WHO/TGA

20082006

CRO (BA/BE studies, Clinical trials)

Centaur House - Mumbai

Formulations

Strong presence in Asia, South America and Africa

Pan India reach- 1150 Sales force 250,000 doctors & 250,000 Pharmacies

50 million prescriptions generated annually by doctors of all specialities

Sinarest- Brand leader in anticold segment, generates 1 prescription every second

Leadership in 6 therapy areas across respiratory and ophthalmic categories

Two WHO - GMP approved formulations facilities in Goa

•

•

•

•

•

•

International standard CRO, focused on clinical trials & BA-BE studies

10,000 square feet, with a CPU and fully equipped ICU

•

•

LifeSan,

Contract research

• Fully integrated setup to drive synergies across R&D, API,

formulations, clinical trials and contract manufacturing

• Vision- 'Global pharmaceutical player providing

end to end solutions’

Strategy

• State-of-the-art bioanalytical unit

• International standard R&D laboratories dedicated to API and formulations

development

R&D Formulations withAnalytical Development

- Pune

2010

API-AmbernathAdditional product lines,

capacity doubled

2010

2011 2016

22%

6% 0%

72% 16%

27%

1%

56%

Showcase

Fluid Bed Processor

Compression Machine

Autocoater DSC/TGA

Reaction Vessel

XRD

NMR

ICU

CPU

LC - MS/MS

Rapid Mixer Granulator

Formulations API

HPLC

R&D / CRO

@APIemail: export@centaurchem.comWebsite: www.centaurchem.com

Formulations email:

Website: www.centaurpharma.comexport@centaurchem.com

Contract research email: lifesan@lifesan.inWebsite: www.lifesan.in

Contract manufacturingemail: centaur_pune@centaurlab.co.in

Website: www.centaurpharma.com

CP

HI -

20

12

- 2

013

email: centaurWebsite: www.centaurpharma.com

@centaurlab.com

Corporate HeadquartersCENTAUR HOUSE,

Vakola, Santacruz (E), Mumbai-400 055, INDIA Tel. : +91-22-6649 9100

Fax : +91-22-6649 9108 / 112